CompanyDeals

Porton Biologics and Royaltech Med Partner on Bacterial and mRNA Drug Platforms

CompanyPolicy / Regulatory

NMPA Suspends UCB’s Keppra Over Labeling Issues, Prompting Recall

CompanyDeals

Biocytogen and Merck KGaA Ink Global Deal for RenMice Platform Licensing

Company

3SBio Inc. Reports H1 2020 Revenue of RMB 3.091B, Net Profit Up 6.19%

Company

Betta Pharmaceuticals’ H1 2022 Revenues Rise 8.5% on Drug Sales Growth

CompanyDrug

Ranok Therapeutics Doses First Patient in RNK05047 Study for BRD4-Targeted Cancers

CompanyDrug

CSPC Pharmaceutical’s SYS6006 mRNA Vaccine Shows Strong Safety and Efficacy in Trials

Policy / Regulatory

China’s Health Commission Promotes Medical-Elderly Care Integration

Policy / Regulatory

China Passes WHO NRA Evaluation for Vaccine Regulatory System

CompanyDrug

SinoMab Bioscience’s SN1011 Gets NMPA Nod for NMOSD Trial

CompanyDrug

Mabwell Bioscience Receives NMPA Approval for 6MW3511 Clinical Trial in Solid Tumors

CompanyDrug

Bio-Thera Solutions Receives NMPA Approval for BAT8008 Clinical Trial in Solid Tumors